UK Markets open in 17 mins

ABIVAX Société Anonyme (0RA9.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
7.14+0.01 (+0.15%)
At close: 04:55PM GMT
Full screen
Loading interactive chart…
  • EQS Group

    Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action

    EQS-News: ABIVAX / Key word(s): Scientific publicationAbivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action 05.01.2023 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action The scientific article in the peer-reviewed journal Clinical and Translational Gastroenterology describes obefazimod’s capacity to selectively up-regulate a si

  • EQS Group

    Abivax receives FDA agreement on pediatric development plan with obefazimod in IBD

    EQS-News: ABIVAX / Key word(s): StudyAbivax receives FDA agreement on pediatric development plan with obefazimod in IBD 20.12.2022 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax receives FDA agreement on pediatric development plan with obefazimod in IBDThe FDA agreed on the initial Pediatric Study Plan (iPSP) for the development of obefazimod in children aged 2 to 17 years with inflammatory bowel diseases (IBD)Abivax global Phase 3 clinical program (

  • EQS Group

    Abivax to attend the J.P. Morgan 41st Annual Healthcare Conference

    EQS-News: ABIVAX / Key word(s): ConferenceAbivax to attend the J.P. Morgan 41st Annual Healthcare Conference 14.12.2022 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.ABIVAX TO ATTEND THE J.P. MORGAN 41ST ANNUAL HEALTHCARE CONFERENCEAbivax’s senior executive management will attend the J.P. Morgan 41st Annual Healthcare Conference and the 12th Annual LifeSci Partners Corporate Access Event from January 9-12 in San Francisco, USPARIS, France, December 14, 202